3D bioprinted GelMA/GO composite induces osteoblastic differentiation.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Traditional bone grafts face limitations like stress shielding and structural inflexibility, particularly for congenital defects.
• Regenerative approaches using mesenchymal stem cells (MSCs) show promise for bone repair.
• Developing advanced bioinks is crucial for creating functional bone scaffolds.

Purpose of the Study:

• To develop a composite bioink by blending graphene oxide (GO) with MSCs and gelatin methacrylate (GelMA) for craniofacial bone regenerative repair.
• To evaluate the viability, proliferation, and osteogenic capacity of MSCs within the GO-GelMA composite bioink.
• To assess the potential of the composite scaffold for enhanced bone regeneration.

Main Methods:

• Fabrication of a composite bioink using GelMA, MSCs, and GO.
• Assessment of MSC viability, proliferation, and printability within the bioink.
• Analysis of osteogenesis-related gene and protein expression (e.g., alkaline phosphatase, osteopontin, osteocalcin, RUNX2) via assays and immunofluorescence.
• Comparison of the GO-GelMA composite with pure GelMA scaffolds.

Main Results:

• The inclusion of GO did not negatively impact MSC viability or the printability of the GelMA bioink.
• GO incorporation significantly enhanced MSC proliferation and adhesion compared to pure GelMA.
• GO promoted osteogenic differentiation, evidenced by increased alkaline phosphatase expression and upregulation of key osteogenic markers (osteopontin, osteocalcin, RUNX2).

Conclusions:

• The developed GO-MSC-GelMA composite bioink effectively supports MSC proliferation and osteogenic differentiation.
• This composite material presents a viable strategy for creating regenerative scaffolds for craniofacial bone repair.
• The study highlights the potential of GO as a component in bioinks for enhancing bone tissue engineering applications.